Skip to content

CFA Pharma: what changed

BE 0428.715.650NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€6,743
2024 · €26,656-€19,913
Equity
€153,937
2024 · €153,194+€743
Cash
€6,105
2024 · €7,679-€1,575
Balance sheet total
€525,286
2024 · €389,747+€135,539

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€118,463

    up €118,463 (+90.9%), from €130,288 to €248,751

    of which Land and buildings: +€136,463

  • Receivables within one year +€18,651

    up €18,651 (+7.4%), from €251,780 to €270,431

    of which Other amounts receivable: +€151,268

Equity and liabilities
  • Debts after one year +€107,871

    up €107,871 (+68.0%), from €158,599 to €266,470

    of which Financial debts: +€107,871

  • Current portion of long-term debt +€8,908

    up €8,908 (+29.8%), from €29,846 to €38,753

  • Trade debts +€7,478

    up €7,478 (+19.6%), from €38,108 to €45,587

  • Other debts +€6,000

    up €6,000 (+60.0%), from €10,000 to €16,000

Income statement
  • Depreciation +€9,673

    up €9,673 (+53.7%), from €18,000 to €27,673

  • Taxes +€4,331

    up €4,331 (+2,086%), from €208 to €4,539

  • Financial charges +€3,340

    up €3,340 (+47.9%), from €6,974 to €10,314

  • Other operating charges +€1,740

    up €1,740 (+151%), from €1,150 to €2,890

  • Gross operating margin -€584

    down €584 (-1.1%), from €52,742 to €52,159

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €26,656
Gross operating margin -€584
Depreciation -€9,673
Other operating charges -€1,740
Financial income -€245
Financial charges -€3,340
Taxes -€4,331
Result 2025 €6,743
lowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€33,781
Investment -€146,135
Financing +€110,779
Cash 2024 €7,679
Net result for the year +€6,743
Depreciation +€27,673
Receivables within one year -€18,651
Trade debts +€7,478
Tax, wage and social debts +€4,539
Other debts +€6,000
Investment in fixed assets (net) -€146,135
Debts after one year +€107,871
Current portion of long-term debt +€8,908
Contributions, distributions and other -€6,000
Cash 2025 €6,105
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €389,747 €525,286 +€135,539 +34.8%
Fixed assets 21/28 €130,288 €248,751 +€118,463 +90.9%
Tangible fixed assets 22/27 €130,288 €248,751 +€118,463 +90.9%
Land and buildings 22 - €136,463 +€136,463
Other tangible fixed assets 26 €130,288 €112,288 -€18,000 -13.8%
Current assets 29/58 €259,459 €276,536 +€17,076 +6.6%
Amounts receivable within one year 40/41 €251,780 €270,431 +€18,651 +7.4%
Trade receivables 40 €171,881 €39,264 -€132,616 -77.2%
Other amounts receivable 41 €79,899 €231,167 +€151,268 +189%
Cash at bank and in hand 54/58 €7,679 €6,105 -€1,575 -20.5%
Total equity and liabilities 10/49 €389,747 €525,286 +€135,539 +34.8%
Equity 10/15 €153,194 €153,937 +€743 +0.5%
Contributions 10/11 €28,000 €28,000 = 0.0%
Reserves 13 €97,165 €97,907 +€743 +0.8%
Non-distributable reserves 130/1 €2,800 €2,800 = 0.0%
Reserves not available under the articles 1311 €2,800 €2,800 = 0.0%
Distributable reserves 133 €94,365 €95,107 +€743 +0.8%
Profit (loss) carried forward 14 €28,030 €28,030 = 0.0%
Amounts payable 17/49 €236,553 €371,349 +€134,796 +57.0%
Amounts payable after more than one year 17 €158,599 €266,470 +€107,871 +68.0%
Financial debts 170/4 €148,599 €256,470 +€107,871 +72.6%
Trade debts 175 €10,000 €10,000 = 0.0%
Amounts payable within one year 42/48 €77,954 €104,879 +€26,925 +34.5%
Current portion of amounts payable after more than one year 42 €29,846 €38,753 +€8,908 +29.8%
Trade debts 44 €38,108 €45,587 +€7,478 +19.6%
Suppliers 440/4 €38,108 €45,587 +€7,478 +19.6%
Taxes, remuneration and social security 45 - €4,539 +€4,539
Taxes 450/3 - €4,539 +€4,539
Other amounts payable 47/48 €10,000 €16,000 +€6,000 +60.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €18,000 €27,673 +€9,673 +53.7%
Other operating charges 640/8 €1,150 €2,890 +€1,740 +151%
Gross operating margin 9900 €52,742 €52,159 -€584 -1.1%
Operating profit (loss) 9901 €33,592 €21,596 -€11,996 -35.7%
Financial income 75/76B €246 €0 -€245 -99.9%
Recurring financial income 75 €246 €0 -€245 -99.9%
Financial charges 65/66B €6,974 €10,314 +€3,340 +47.9%
Recurring financial charges 65 €6,974 €10,314 +€3,340 +47.9%
Profit (loss) for the period before taxes 9903 €26,863 €11,282 -€15,582 -58.0%
Income taxes 67/77 €208 €4,539 +€4,331 +2,086%
Profit (loss) for the period 9904 €26,656 €6,743 -€19,913 -74.7%
Profit (loss) for the period to be appropriated 9905 €26,656 €6,743 -€19,913 -74.7%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€117,497 to €133,709

Midpoint €124,252 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €153,937
Capitalised earnings €81,057 to €113,480
Indication €117,497 to €133,709

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€153,937
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€153,937

Capitalised earnings

net result for the year (9904)
2025
€6,743
2024
€26,656
2023
€645
2022
€27,199
2021
€24,625
Average result
€11,348
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€81,057 / €94,567 / €113,480

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.